Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Gold Standard Diagnostics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Gold Standard Diagnostics

Gold Standard Diagnostics

Pre-Seed

Gold Standard Diagnostics offers products, services, and consultancy for the medical community.

HQ
Davis, CA, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

Founded to enhance the diagnostic and medical communities, Gold Standard Diagnostics focuses on providing comprehensive products, services, and consultancy solutions. Their core mission is to improve laboratory efficiency and reduce costs through a wide range of diagnostic tools, including PCR, ELISA, and Lyme disease testing solutions. The company aims to simplify laboratory experiences with an extensive product menu and exceptional customer service, targeting medical professionals and laboratories.

Gold Standard Diagnostics has garnered attention through its innovative approach and commitment to quality. Notable affiliations include partnerships with leading healthcare institutions and investments from key players in the medical diagnostics industry. The company’s achievements include the development of advanced diagnostic assays and instruments that have significantly impacted lab operations. Overall, Gold Standard Diagnostics has made a substantial impact by enhancing diagnostic accuracy and operational efficiency in medical laboratories.

Gold Standard Diagnostics - Quick Facts

When was Gold Standard Diagnostics founded?

Gold Standard Diagnostics was founded in 2006.

Where is Gold Standard Diagnostics' headquarters located?

Gold Standard Diagnostics' headquarters is located in Davis, CA, US.

When was Gold Standard Diagnostics' last funding round?

Gold Standard Diagnostics' most recent funding round was for $1M (USD) in February 2013.

How much has Gold Standard Diagnostics raised to-date?

As of Feb 11, 2013, Gold Standard Diagnostics has raised a total of $2.5M (USD).

How many employees does Gold Standard Diagnostics have?

Gold Standard Diagnostics has 32 employees as of Feb 5, 2024.

Gold Standard Diagnostics - Classification

Technology
  • ELISA
  • PCR
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Services
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Diagnostic Solutions
Tags
  • Biotech
  • Healthcare
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 8690Other human health activities
Show 6 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621500Medical and Diagnostic Laboratories
  • 621510Medical and Diagnostic Laboratories
  • 621511Medical Laboratories
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories